Notice of first launch, interruption or termination of supply of a human drug
 Date ▲HolderCodeDrugDate fromSubject
 28.2.2024BAUSCH HEALTH IRELAND LIMITED (BAU-3)2850ERalbior 5 mg/2,5 mg (cps dur 30x5 mg/2,5 mg (blis.BOPA/Al/PVC laminát/Al))1.3.2024U
 28.2.2024BELUPO, s.r.o. (BLU-SK)38084URUTAL 16 mg (tbl 60x16 mg (blis.PVC/PVDC/Al))28.2.2024R
 28.2.2024Zentiva, k.s. (ZNT-1)01069Fungicidin Léčiva (ung 1x10 g (tuba Al))4.3.2024O
 28.2.2024Zentiva, k.s. (ZNT-1)2512DZetovar 10 mg/40 mg tablety (tbl 30x10 mg/40 mg (blis.OPA/Al/PVC))4.3.2024O
 28.2.2024Zentiva, k.s. (ZNT-1)7290CLopridam 8 mg/2,5 mg/10 mg (tbl 30x8 mg/2,5 mg/10 mg (blis.OPA/Al/PVC/Al))4.3.2024O
 28.2.2024Zentiva, k.s. (ZNT-1)2452EDaruph 55 mg (tbl flm 60x55 mg (blis.OPA/Al/PVC/Al))29.6.2023U
 28.2.2024Zentiva, k.s. (ZNT-1)2456EDaruph 79 mg (tbl flm 30x79 mg (blis.OPA/Al/PVC/Al))29.6.2023U
 28.2.2024BELUPO, s.r.o. (BLU-SK)20379URUTAL 24 mg (tbl 50x24 mg (blis.PVC/PVDC/Al))28.2.2024R
 28.2.2024Bayer AG (BYE-4)03134Gadovist 1,0 mmol/ ml (sol iru 5x7,5 ml (striek.inj.napl.skl.))28.2.2024O
 28.2.2024Viatris Healthcare Limited (VIM-1)25255AFONILUM SR 125 (cps plg 50x125 mg (blis.PVC/Al))8.3.2024R
 28.2.2024Viatris Healthcare Limited (VIM-1)6610BCholib 145 mg/20 mg filmom obalené tablety (tbl flm 90x145 mg/20 mg (blis.Al/Al))8.3.2024R
 28.2.2024Baxalta Innovations GmbH (BXA)1889CCuvitru 200 mg/ml (sol inj 1x10 ml (liek.inj.skl.))28.2.2024O
 28.2.2024Egis Pharmaceuticals PLC (EGI)2345ATelmisartan EGIS 40 mg (tbl flm 98x40 mg (blis.Al/Al))28.2.2024O
 28.2.2024TILLOMED PHARMA GmbH (TLT-2)2375EFoscarnet Tillomed 24 mg/ml infúzny roztok (sol inf 1x250 ml/6 000 mg (fľ.skl.))1.3.2023R
 28.2.2024Quintesence s.r.o. (QNS-1)00248Panthenol 100 mg JENAPHARM (tbl 20x100 mg (liek.skl.hnedá))28.2.2024O

Subject means:
U-Placement of medicine to Slovakian market, R-Discontinuation of medicine supply to Slovakian market,
O-Resumption of medicine supply to Slovakian market, Z-Cancelation of medicine supply to Slovakian market


Date from
From
To



 
Processed by the system MCR.Prerusenie (8.0)